Pine Labs Ltd Q1 FY27 Results

Pine Labs guided to 21–23.5% FY27 revenue growth with Q1 at the lower end of that range (~21% YoY). In FY26, the company posted 19% growth and its first full-year net profit of ₹113 Cr, closing a years-long march to profitability. The question: is Q1 tracking that guidance despite the July churn (Setu leadership exit, trading window closure, new acquisition still ramping)?

Strong print: Revenue ₹295–300+ Cr (21%+ growth), EBITDA margins stable or expanding YoY despite Shopflo costs, net profit >₹5 Cr (EPS >2.5x prior year), and management commentary that gift-card revenue is on-plan and Shopflo integration on track. Guidance confirmation for FY27 21–23.5% and margin outlook. Weak print: Revenue 100bps YoY due to integration drag or geographic softness; net profit flat or below ₹4 Cr; any guidance withdrawal or commentary that Setu churn or Middle East/airline sector slowdown is more pronounced than expected.

Yes, on the surface. Management stated just weeks ago (around June 16 Investor Day) that they are already seeing Q1 numbers roll in and feel confident about the 21–23.5% FY27 guidance, even accounting for noted softness in the Middle East and airline verticals. FY26 momentum (₹113 Cr net profit, 19% growth, 68% UPI growth) and a strong balance sheet after the IPO support execution. However, two wildcards: (1) the Setu leadership transition (Anand Raisinghani, President & CBO, resigned July 17; effective same day)—low headline risk but watch operational cadence in the month ahead—and (2) the Shopflo integration (deal closed June 10, so only ~20 days of contribution in Q1)—contribution immaterial, but management's confidence on synergy timing matters.

Last 6 months: HRTI (June 24, bulk buy 60.9M @ ₹157.83, bulk sell 48.3M @ ₹157.68) on same day—likely internal rebalance. Actis Pine Labs Investment Holdings (promoter-linked entity) sold 98.3M shares June 19 @ ₹154.25. Invesco Emerging Markets Fund sold 78.9M June 5 @ ₹145.97. Madison India Opportunities IV sold 2.48Cr shares May 22 @ ₹144 (the May low); Templeton funds and ICICI Prudential bought 1.79–4.9M each @ ₹144 (accumulation at lows). Signal: Promoter-linked exit (Actis June), but foreign / domestic funds accumulating on weakness (May–Jun). No major insider pledging risk flagged. DII accumulation is a positive structural signal into the results.

Pine Labs' first full quarter reported as a listed company (it listed in November 2025) delivered consolidated revenue of Rs736.92 Cr, up 19.7% YoY and 5.2% sequentially, with profit after tax quadrupling to Rs19.57 Cr from Rs4.79 Cr a year ago. More telling than the PAT multiple is the pre-tax swing: consolidated PBT turned to a positive Rs37.73 Cr from a Rs4.84 Cr loss in Q1 FY26 — the print carries the 'first full year of profitability' narrative into FY27.

The profit came without any exceptional help — this quarter has no one-offs, unlike Q4 FY26 which booked an Rs8.93 Cr labour-code provision write-back plus a large deferred-tax credit that inflated that quarter's PAT to Rs59.36 Cr. That base effect makes the 67% QoQ PAT drop misleading; on a clean YoY basis the result shows genuine operating leverage, with net margin expanding to 2.7% from 0.8% a year ago. Contribution margin held at 72.3% (Rs533 Cr) and adjusted EBITDA reached Rs126 Cr (17.1% margin). Growth was led by the Issuing & Acquiring platform (revenue +31% YoY) alongside the larger Digital-infrastructure segment; international revenue rose 21% YoY to Rs114 Cr, ~16% of the consolidated mix, across 22 countries.

The stock went into the print at ₹147.64, down 6.9% over the past month of trading.

Against management's FY27 revenue-growth guidance of 21-23.5%, Q1's ~20% lands just at/below the lower end — but management had explicitly guided Q1 to the bottom of the range with H2 acceleration as new IAP categories (gaming gift cards with Xbox/Roblox/Nintendo, prepaid programmes) scale, so the print is on-plan rather than a miss. The Street carries a 'Strong Buy' consensus (7 of 8 analysts, ~Rs206 avg 12-month target) but no published Q1 numeric estimate, so this reads broadly in-line. A note on basis: standalone PAT was Rs43.66 Cr on Rs535 Cr revenue (rev +25% YoY, PAT +55% YoY) — the parent is materially more profitable and growing faster than the consolidated entity, which is diluted by subsidiary and international losses; readers seeing the two numbers side by side should treat standalone as the parent-only view.